mebendazole has been researched along with Ascites in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinto, LC | 1 |
| Mesquita, FP | 1 |
| Soares, BM | 1 |
| da Silva, EL | 1 |
| Puty, B | 1 |
| de Oliveira, EHC | 1 |
| Burbano, RR | 1 |
| Montenegro, RC | 1 |
1 other study available for mebendazole and Ascites
| Article | Year |
|---|---|
Mebendazole induces apoptosis via C-MYC inactivation in malignant ascites cell line (AGP01).
Topics: Apoptosis; Ascites; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Damage; Humans; Lymphocytes; Me | 2019 |